| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study G Prucher, M Assenza, B Binda, M Biondi, G Brachini, P Bruzzaniti, ... Anaesthesia 76 (6), 748-758, 2021 | 476 | 2021 |
| Community health workers for ART in sub-Saharan Africa: learning from experience–capitalizing on new opportunities K Hermann, W Van Damme, GW Pariyo, E Schouten, Y Assefa, A Cirera, ... Human resources for health 7, 1-11, 2009 | 302 | 2009 |
| Community health extension program of Ethiopia, 2003–2018: successes and challenges toward universal coverage for primary healthcare services Y Assefa, YA Gelaw, PS Hill, BW Taye, W Van Damme Globalization and health 15, 1-11, 2019 | 271 | 2019 |
| A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection K Ritmeijer, A Dejenie, Y Assefa, TB Hundie, J Mesure, G Boots, ... Clinical Infectious Diseases 43 (3), 357-364, 2006 | 235 | 2006 |
| National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990–2015: findings from the Global Burden of Disease Study 2015 A Misganaw, TN Haregu, K Deribe, GA Tessema, A Deribew, YA Melaku, ... Population health metrics 15, 1-17, 2017 | 198 | 2017 |
| The COVID-19 pandemic: diverse contexts; different epidemics—how and why? W Van Damme, R Dahake, A Delamou, B Ingelbeen, E Wouters, ... BMJ global health 5 (7), e003098, 2020 | 173 | 2020 |
| Successes and challenges of the millennium development goals in Ethiopia: lessons for the sustainable development goals Y Assefa, W Van Damme, OD Williams, PS Hill BMJ global health 2 (2), e000318, 2017 | 169 | 2017 |
| Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects Y Assefa, D Jerene, S Lulseged, G Ooms, W Van Damme PLoS medicine 6 (4), e1000056, 2009 | 134 | 2009 |
| The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response GA Tessema, Y Kinfu, BA Dachew, AG Tesema, Y Assefa, KA Alene, ... BMJ global health 6 (12), e007179, 2021 | 131 | 2021 |
| Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia E Tagar, M Sundaram, K Condliffe, B Matatiyo, F Chimbwandira, ... PloS one 9 (11), e108304, 2014 | 106 | 2014 |
| COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics? W Van Damme, R Dahake, R Van de Pas, G Vanham, Y Assefa Medical hypotheses 146, 110431, 2021 | 96 | 2021 |
| Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation Y Assefa, WV Damme, DH Mariam, H Kloos AIDS patient care and STDs 24 (8), 521-525, 2010 | 90 | 2010 |
| Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia E Diro, Y Techane, T Tefera, Y Assefa, T Kebede, A Genetu, Y Kebede, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 101 (9 …, 2007 | 82 | 2007 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 81 | 2022 |
| Universal voluntary HIV testing and immediate antiretroviral therapy. Y Assefa, M Lera Lancet 373 (9669), 1080-1, 2009 | 74* | 2009 |
| Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities Y Assefa, A Kiflie, D Tesfaye, DH Mariam, H Kloos, W Edwin, M Laga, ... BMC health services research 11, 1-7, 2011 | 73 | 2011 |
| Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013 Y Assefa, A Alebachew, M Lera, L Lynen, E Wouters, W Van Damme Globalization and health 10, 1-10, 2014 | 69 | 2014 |
| Ending the epidemic of HIV/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries? Y Assefa, CF Gilks International Journal of Infectious Diseases 100, 273-277, 2020 | 66 | 2020 |
| Primary health care contributions to universal health coverage, Ethiopia Y Assefa, PS Hill, CF Gilks, M Admassu, D Tesfaye, W Van Damme Bulletin of the World Health Organization 98 (12), 894, 2020 | 60 | 2020 |
| Effectiveness and acceptability of delivery of antiretroviral treatment in health centres by health officers and nurses in Ethiopia Y Assefa, A Kiflie, B Tekle, DH Mariam, M Laga, W Van Damme Journal of health services research & policy 17 (1), 24-29, 2012 | 56 | 2012 |
